Revolutionizing Colon Cancer

With Targeted Immunotherapy

Colon cancer can be a tough cookie to treat through traditional pharma. Precise staging, strong consideration of comorbidities, and complex surgical care must be taken to arrive at a safe and productive treatment plan that preserves digestive function — especially if age is a factor.

The Immunocine Cancer Center is committed to serving up an alternative with fewer risks and more resilience.

An Oncological Breakthrough:

Hope Is On the Horizon

Although a person can develop colorectal cancer at any stage of life, the demographic most often afflicted is also the most difficult to treat with chemotherapy medications and colon-related surgical procedures.

Since life-threatening complications can arise, many colon cancer patients ages 65 and older are not able to find a promising treatment plan. Yet, the number of reported cases continues to rise every year.

Today, young people still predominate the slots in immunotherapy clinical trials, leaving those with the least options underrepresented and unable to participate. Immunocine opened its doors to change that.

Real Results with Colon Cancer

Vanessa B.

Colon Cancer 

After two years of chemotherapy and countless visits at two different hospitals, Vanessa B. Was told by doctors that there was nothing more they could do about her colon cancer. She describes her acceptance into an immunotherapy clinical trial at the John Hopkins Cancer Center as a gleam of light that had come down on the heavens and shown upon her.

She had always wanted to see her grandchildren graduate from high school and go off to college, and immunotherapy granted her just that.

Immunocine welcomes patients whom we’ve screened for success.

Although we wish we could treat everyone’s cancer, we use these criteria to seek out candidates that can truly benefit.

Tumor Access

Biopsying a solid tumor is a big step in our protocol to shrink it.

Immune Capacity

An immune system has to pull its weight for our treatment to work.

Transportation Ability

We can only administer cancer treatment at our Cancún facility.

Analogous Schedule

We must see a patient three times two weeks apart to treat them.

Rectifying the Risks

of Colorectal Cancer

Restricted Options

Precise staging is a crucial part of treating colorectal cancer, as collateral damage to the structures around it can have life-altering consequences. To preserve digestive and bowel function (as well as fertility, if applicable) surgeries and chemotherapies must be carefully considered. The sheer amount of risk involved often revokes access for patients of riper age.

Immunotherapy targets these tumors with very low risk or restriction.

Liver Metastasis

A hepatic portal vein connects the large intestine to the liver, allowing 70% of colorectal cancers to spread to this other major organ. Liver surgery also comes with risk, so most patients opt for radiofrequency ablation. This does not slow the frequency of metastasis or recurrence.

Immune interference can not only slow but restrain these mechanisms.

Moving Oncology Toward

More Positive Outcomes

Clinical Prestige

We stand behind our work, as do clinical successes, patents, 17 publications, and 15 years of passionate research.

Multidisciplinary Staff

We are primarily a medical facility, but the letters after our names prove that we are so much more.

Haven For Healing

We have created an extraordinarily clean and cordial space to heal by following cGMP standards and our hearts.

Frequently Asked Questions

Immunotherapy is a technique to take down cancerous colorectal cells without the harsh drawbacks or wasted energy of traditional methods. A one-size-fits-all radiation wave or chemical can’t always fit the bill, so this flips it over and riles up the immune system to fight cancer from within.

So, how does it work? During Immunocine’s Dendritic Cell Treatment, a patient’s dendritic cells receive a ‘blueprint’ of the same cancer cells that are ailing the patient and are then reintroduced to the body. This creates a personalized colorectal cancer treatment that truly ‘knows’ its target.

To qualify for our colorectal cancer treatment protocol, a patient must:

– Have a functional immune system
– Have a solid, testable tumor
– Be able to travel to Cancún

Should they meet these ‘musts’, we will review their medical records in detail to determine their candidacy. This can take up to two weeks and will not cost them. Once we have arrived at a decision, our concierge team will set up a call to discuss travel arrangements and treatment plans.

Some side effects have been reported, but they tend to be mild and mimic the flu. Feeling tired, achy, feverish, or less hungry can actually signal that the immune system took to the treatment and is fighting.

Depending on where colon cancer sits in the GI tract and whether it has spread to other areas, gastrointestinal upset or dull pain could also crop up for some. Our nutrition specialist can offer customized counsel, and all side effects should subside completely within a matter of weeks.

Immunotherapy is changing the way we think about colon cancer.

Before this oncological breakthrough, effective treatment plans had to be carefully curated, came with serious disclaimers attached, and were detrimentally hard for the elderly to acquire. Despite frantic efforts from experts in the field of oncology, colorectal cancer remains the second most deadly cancer and still recurs more frequently than almost any other.

For decades, immunotherapy clinical trials have been the sole road certain patients could take to increase their chances of reaching a future destination — like Vanessa B.’s plans to see her grandchildren graduate high school and head off to college from the success story above.

The Immunocine Cancer Center is widening the highway to hope.

Apply today for a new approach to

your Colon Cancer.

Once you submit your information form, we initiate a dedicated and personalized journey to provide you the most innovative prostate cancer treatments.

Step 1: Connecting with a Patient Coordinator

Upon receiving your submission, an Immunocine Patient Coordinator will contact you to schedule an introductory call.

This gives us an opportunity to get to know you, understand your needs better, and answer any preliminary questions you may have about our approach to prostate cancer.

Step 2: Complimentary Medical Evaluation

Following the introductory call, we’ll commence your complimentary medical evaluation.

Our goal during the medical evaluation is to determine if you will be a candidate for our treatment. We know waiting can be hard and we aim to complete this process in 3 – 5 business days.

Schedule an Introductory Call